• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.14% Nasdaq Down 0.35%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    2.11 Down 0.06(2.76%) Sep 3, 4:00PM EDT
    Add to Portfolio
    Prev Close:2.17
    Open:2.15
    Bid:2.01 x 1600
    Ask:2.38 x 300
    1y Target Est:2.00
    Beta:-1.43275
    Next Earnings Date:N/A
    Day's Range:2.10 - 2.24
    52wk Range:1.69 - 5.48
    Volume:616,168
    Avg Vol (3m):1,604,060
    Market Cap:199.66M
    P/E (ttm):N/A
    EPS (ttm):-0.51
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    IMMUDown 2.76%199.66M
    GSKDown 0.05%98.18B
    BIIBDown 0.85%70.93B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):36.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-16) :-0.33
    Quarterly EPS Est (Sep-15) :-0.14
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback